3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
54
Squamous Cell Carcinoma of Head and Neck
4
Sarcoma
4
Neoplasm Metastasis
4
Sarcoma, Ewing
3
Neoplasms
3
Medulloblastoma
3
Lymphoma, Non-Hodgkin
3
Glioma
3
Carcinoma, Non-Small-Cell Lung
3
Astrocytoma
3
Wilms Tumor
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Osteosarcoma
2
Oligodendroglioma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Lymphoma
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioblastoma
2
Ependymoma
2
Colonic Neoplasms
2
Xanthogranuloma, Juvenile
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Recurrent Squamous Cell Lung Carcinoma
1
Interventions
Radiotherapy
11
Cisplatin
10
Paclitaxel
9
pembrolizumab
7
Fluorouracil
7
Oxaliplatin
6
Irinotecan
6
tislelizumab
5
Cetuximab
5
Docetaxel
4
Radiation
3
Nivolumab
3
Leucovorin
3
Carboplatin
3
Capecitabine
3
Neoadjuvant Therapy
2
Immunohistochemistry
2
Biopsy
2
10-propargyl-10-deazaaminopterin
2
tremelimumab
1
sitravatinib
1
sintilimab
1
regorafenib
1
pegylated granulocyte colony-stimulating factor, human
1
pegfilgrastim
1
oblimersen
1
durvalumab
1
cixutumumab
1
adavosertib
1
Taxes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Esophageal Squamous Cell Carcinoma
×
palbociclib
×
Clear all
No trials found.